Background Acute and delayed haemolysis, alloimmunisation and pure red cell aplasia
(PRCA) are potential complications after ABO incompatible haematopoietic stem cell …

BACKGROUND: Most studies indicate that ABO incompatibility has no effect on the clinical
outcome after allogeneic peripheral blood progenitor cell (PBPC) transplantation (allo …

BACKGROUND Hemolysis at the time of graft infusion is one of the immediate complications
in major ABO‐incompatible allogeneic hematopoietic stem cell transplants (HSCTs). We …

Apart from solid organ transplantations, use of ABO-blood group mismatched (ABO-
mismatched) donors is acceptable in hematopoietic stem cell transplantation (HSCT) …

Background and Objectives In the setting of major ABO‐incompatible allogeneic
haematopoietic stem cell transplantation (HSCT), pure red cell aplasia (PRCA) is linked to …

Objective ABO mismatch between donor and recipient occurs in 40% of allogeneic
hematopoietic stem cell transplantations (HCT). Different strategies have been described to …

BACKGROUND: Bone marrow transplantation with minor ABO incompatibility may be
followed by moderate delayed hemolysis of the recipient's red cells by donor‐derived ABO …

Blood group incompatibility between donor and recipient of allogeneic stem cell transplants
may be associated with post-transplant erythroid aplasia. A total of 548 patients (pts) …

Owing to the limitations of donor availability, about 30–50% of allogeneic haematopoietic
stem cell transplantations (HSCTs) are carried out between blood type A, B or O (ABO) …

BACKGROUND: Changes within the ABO system are regularly observed phenomena in
allogeneic bone marrow transplantation (BMT) and peripheral blood progenitor cell …